Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Leukemia, Promyelocytic, Acute × Daunorubicin × Clear all

Phase

Phase 3 2 Phase 2 2 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Neoplasm, Residual 3 Lymphoma 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1

Interventions

Idarubicin 3 Arsenic Trioxide 3 Mitoxantrone 2 Cytarabine 2 Tretinoin 1 Transplantation, Autologous 1 Thiotepa 1 Radiotherapy 1 Filgrastim 1 Daunorubicin 1 Cyclophosphamide 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00180128 2011-07-11

AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia

Technische Universität Dresden

Phase 4 Unknown

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡